Melatonin Xl Activase (Melatonin)

Melatonin acts as an agonist at the MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. Binding to these receptors mimics the natural rise of melatonin at night, signaling darkness, reducing neuronal activity that promotes wakefulness, and thereby promoting the initiation and maintenance of sleep.

The appropriate dose of Melatonin Xl Activase is determined by the prescribing healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for melatonin use in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Melatonin Xl Activase, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with prescription hypnotics such as benzodiazepines, melatonin has a distinct mechanism focused on circadian regulation rather than direct central nervous system depression, resulting in a lower risk of dependence. Unlike antihistamine sleep aids, melatonin does not cause anticholinergic side effects, making it a preferable option for many patients when appropriate.

Melatonin Xl Activase should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

The product is taken orally, usually with a small amount of water. It can be taken with or without food, although some patients prefer taking it 30‑60 minutes before bedtime to align with the natural rise in endogenous melatonin.

Serious but rare risks include allergic reactions such as rash, swelling or difficulty breathing, severe hypotension, and significant mood alterations including depression or heightened anxiety. Patients should seek immediate medical attention if any of these symptoms occur.

Melatonin Xl Activase is not recommended for children unless prescribed by a pediatric specialist, for individuals with known hypersensitivity to melatonin, or for patients with severe hepatic impairment without medical supervision. Consultation with a healthcare professional is essential before starting therapy.